Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514291 | SCV000610944 | likely benign | not provided | 2017-04-10 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000514291 | SCV000841179 | benign | not provided | 2018-02-28 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000729024 | SCV000856658 | benign | not specified | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000514291 | SCV001101772 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514291 | SCV001851104 | benign | not provided | 2020-07-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506246 | SCV002808230 | likely benign | X-linked Alport syndrome | 2022-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962422 | SCV004781841 | benign | COL4A5-related condition | 2020-02-05 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |